-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

618.O1.6 618. Acute Myeloid Leukemias: Biomarkers and Molecular Marker in Diagnosis and Prognosis: Refining Diagnostic Risk Assessment

Symposia: Acute Myeloid Leukemias: Biomarkers and Molecular Markers in Diagnosis and Prognosis Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Acute Myeloid Malignancies, AML, Adult, Combination therapy, Translational Research, Clinical Research, Genomics, Health outcomes research, Supportive Care, Diseases, Therapy sequence, Real-world evidence, Treatment Considerations, Registries, Myeloid Malignancies, Biological Processes, Technology and Procedures, Molecular biology, Study Population, Human, Measurable Residual Disease , Molecular testing
Monday, December 9, 2024: 2:45 PM-4:15 PM
Grand Hall B (Manchester Grand Hyatt San Diego)
Moderators:
Monica Cusan, MD, University Hospital, LMU Munich and Francesco Buccisano, MD, University of Rome Tor Vergata
Disclosures:
Buccisano: Servier: Honoraria, Speakers Bureau; Delbert Pharma: Honoraria; Jazz Pharmaceuticals: Honoraria, Speakers Bureau; Novartis: Honoraria.
2:45 PM

Paul Olson1*, Razif Gabdoulline1*, Rabia Shahswar, MD1*, Arnold Kloos1*, Letizia Venturini1*, Isabell Arnhardt1*, Henri C. Hupe1*, Victoria Panagiota, MD2*, Michael Stadler1*, Matthias Eder, MD2*, Gernot Beutel, MD2*, Elke Dammann1*, Piroska Poll, MD2*, Anke Bergmann3*, Nataliya DiDonato3*, Florian H. Heidel, MD2, Felicitas R. Thol, MD1 and Michael Heuser, MD1,4

1Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
2Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
3Department of Human Genetics, Hannover Medical School, Hannover, Germany
4Department of Internal Medicine IV, University Hospital Halle (Saale), Halle, Germany

3:00 PM

Mark J. Levis1, Pau Montesinos, PhD, MD2*, Hee-Je Kim3, Radovan Vrhovac, MD, PhD4*, Elzbieta Patkowska5*, Pavel Zak, M.D.6*, Po-Nan Wang, MD7*, Jorge E. Cortes, MD8, Mikkael A. Sekeres, MD9, Hervé Dombret, MD, PhD10, Sergio Amadori, MD11, Jianxiang Wang, MD12, Richard F. Schlenk, MD13*, Alexander E. Perl, MD14, Mitsuhiro Yazawa15*, Jaime E. Connolly Rohrbach, PhD15*, Venkat Thodima15*, Ken C. N. Chang, PhD15*, Li Liu15*, Karima Imadalou, MD15*, Akash Nahar, MD15*, Kristy Burns, PhD15* and Harry P. Erba, MD, PhD16

1Division of Hematologic Malignancies, Johns Hopkins University, Baltimore, MD
2Hematology Department, La Fe University and Polytechnic Hospital, Valencia, Spain
3Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
4Division of Hematology, University Hospital Centre Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia
5Institute of Hematology and Blood Transfusion, Warsaw, Poland
6Department of Internal Medicine—Haematology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
7Chang Gung Medical Foundation, Linkou, Taiwan
8Augusta University Medical Center, Augusta, GA
9Sylvester Cancer Center, University of Miami Health System, Miami, FL
10Saint Louis Hospital, University of Paris, Paris, France
11Tor Vergata Polyclinic Hospital Rome, Rome, ITA
12Institute of Hematology and Blood Diseases Hospital, Tianjin, China
13National Center of Tumor Diseases Trial Center, German Cancer Research Center, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany
14Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, PA
15Daiichi Sankyo, Inc, Basking Ridge, NJ
16Duke Cancer Institute, Durham, NC

3:15 PM

Adam Lamble, MD1, Rhonda E. Ries, MA2*, Jack H. Peplinski, MSc2*, Logan K. Wallace2*, Danielle C. Kirkey, MD2,3, Xiaotu Ma, PhD4 and Soheil Meshinchi, MD, PhD2

1Hematology-Oncology, Seattle Children's Hospital, Seattle, WA
2Translational Science and Therapeutics, Fred Hutchinson Cancer Center, Seattle, WA
3Pediatric Hematology/Oncology, Seattle Children's Hospital, Seattle, WA
4St. Jude Children's Research Hospital, Memphis, TN

3:30 PM

Tariq Kewan, MD1, Arda Durmaz, PhD2*, Waled Bahaj, MD3, Carmelo Gurnari, MD, PhD4,5, Olisaemeka Ogbue, MBBS6,7, Ahmad Kiwan, MD8, Hussein Awada6, Hetty E. Carraway, MD, MBA9, Suresh Kumar Balasubramanian, MD10, Taha Bat11, Yazan F Madanat, MD12,13, Valeria Visconte, PhD2 and Jaroslaw Maciejewski6

1Department of Internal Medicine, Section of Hematology, Yale University, New Haven, CT
2Department of Translational Hematology & Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
3Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH
4Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
5Cleveland Clinic Foundation, Cleveland, OH
6Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
7Fairview Hospital, Cleveland Clinic Foundation, Rocky River, OH
8Yale University, New Haven, CT
9Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
10Department of Oncology, Karmanos Cancer Institute/Wayne State University, Troy, MI
11Department of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, TX
12Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
13University of Texas Southwestern Medical Center, Dallas, TX

3:45 PM

Ali Bazarbachi, MD, PhD1, Jacques-Emmanuel Galimard, PhD2*, Iman Abou Dalle, MD3*, Flore Sicre De Fontbrune4*, Jurjen Versluis, MD, PhD5*, Depei Wu, MD, PhD6, Matthias Eder, MD7*, Hélène Labussière-Wallet, MD8*, Ibrahim Yakoub-Agha, MD, PhD9*, Johan Maertens, MD, PhD10*, Edouard Forcade, MD, PhD11*, Tobias Gedde-Dahl, MD12*, Goda Choi, MD13*, Cristina Castilla-Llorente, MD14*, Frederic Baron15, Eolia Brissot16, Jordi Esteve, MD, PhD17, Arnon Nagler, MD18, Mohamad Mohty, MD, PhD19 and Fabio Ciceri20*

1American University of Beirut Dept. of Medicine, Beirut, Lebanon
2EBMT Paris Study Unit, Saint Antoine Hospital, INSERM UMR-S 938, Sorbonne University, Paris, France
3Bone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut medical center, Beirut, Lebanon
4Hôpital Saint-Louis, Université Paris Cité, Paris, France
5Erasmus University Medical Center Cancer Institute, Rotterdam, Netherlands
6Department of Hematology, The first Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center of Hematologic Diseases, Suzhou, China
7Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
8Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, France
9Lille University Hospital, Lille, France
10Department of Hematology, University Hospital Gasthuisberg, Leuven, Belgium
11Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Bordeaux, Bordeaux, France
12Oslo University Hospital, Rikshospitalet, Oslo, Norway
13University of Groningen, University Medical Center Groningen (UMCG), Groningen, Netherlands
14Gustave Roussy Cancer Campus, Villejuif, France
15University of Liege, Liege, Belgium
16Hematology Department, Hôpital Saint Antoine, Service d'Hématologie et Thérapie Cellulaire, Paris, France, Paris, France
17Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain
18Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Aviv, Israel
19Sorbonne University, Hôpital Saint-Antoine, and INSERM UMRs938, Paris, France
20Hematology and Bone Marrow Transplantation Unit, IRCCS Ospedale San Raffaele, Milan, Italy

4:00 PM

Nikhil Patkar, MD1*, Aarti Ramesh Achrekar, MSc2*, Priyanka Rajesh Ugale, MSc2*, Gojiri Mawalankar, MD2*, Saurabh Kusurkar, MD2*, Shadma Shahin, MD2*, Swapnali Joshi, MSc2*, Seema Biswas, MD2*, Karishma Anam2*, Arpit Mathur2*, Vishram Terse, PhD, MSc2*, Dhanlaxmi Lalit Shetty, PhD, MSc3,4*, Nishant Jindal, MD, DM5*, Prashant Tembhare, MD6*, Sumeet Mirgh, MD, DM7*, Alok Shetty, MD, DM8*, Anant Gokarn, MD, DM7*, Sachin Punatar, MD, DM7*, Lingaraj Nayak, MBBS, MD, DM9*, Hasmukh Jain, MD, DM10*, Manju Sengar, MD, DM10, Navin Khattry, MD, DM7*, Bhausaheb Bagal, MD, DM7*, Sweta Rajpal, MD, DM2,11*, Gaurav Chatterjee, MD, MSc2*, Papagudi Ganesan Subramanian, MD12* and Sumeet Gujral, MD13*

1Department of Hematopathology, Tata Memorial Centre, Mumbai, India
2Department of Hematopathology, ACTREC, Tata Memorial Centre, Navi Mumbai, India
3Tata Memorial Hospital, Mumbai, India
4Cancer Cytogenetics, ACTREC, Tata Memorial Centre, Navi Mumbai, India
5Department of Medical Oncology, ACTREC, Tata Memorial Centre, Navi Mumbai, India
6Department of Hemato Pathology, Tata Memorial Centre, Mumbai, India
7Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, India
8Department of Medical Oncology, Tata Memorial Centre, Mumbai, India
9Department of Medical Oncology, Tata Memorial Centre, MUMBAI, India
10Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India
11Department of Hematopathology, Tata Memorial Centre, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Navi Mumbai, India
12Department of Hematopathology, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, India
13Department of Pathology, Tata Memorial Centre, Mumbai, India

*signifies non-member of ASH